Chronic blockade of angiotensin AT1receptors improves cardinal symptoms of metabolic syndrome in diet-induced obesity in rats

The Concise Guide to PHARMACOLOGY 2013/14: Overview

(2013) Stephen P.H. Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Amlodipine enhances amelioration of vascular insulin resistance, oxidative stress, and metabolic disorders by candesartan in metabolic syndrome rats

(2012) Daisuke Sueta et al.   AMERICAN JOURNAL OF HYPERTENSION

Blood pressure response to angiotensin II is enhanced in obese Zucker rats and is attributed to an aldosterone-dependent mechanism

(2012) Helge Müller-Fielitz et al.   BRITISH JOURNAL OF PHARMACOLOGY

Selective Insulin and Leptin Resistance in Metabolic Disorders

(2012) A. Christine Könner et al.   Cell Metabolism

Improved Insulin Sensitivity after Long-Term Treatment with AT1Blockers Is Not Associated with PPARγ Target Gene Regulation

(2012) Helge Müller-Fielitz et al.   ENDOCRINOLOGY

Double blockade of angiotensin II (AT1)-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats

(2011) Anja Miesel et al.   BRITISH JOURNAL OF PHARMACOLOGY

Weight loss and hypophagia after high-dose AT1-blockade is only observed after high dosing and depends on regular leptin signalling but not blood pressure

(2011) Helge Müller-Fielitz et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Overfeeding-Induced Obesity in Spontaneously Hypertensive Rats: An Animal Model of the Human Metabolic Syndrome

(2010) Anja Miesel et al.   ANNALS OF NUTRITION AND METABOLISM

Guidelines for reporting experiments involving animals: the ARRIVE guidelines

(2010) JC McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

Angiotensin II type 1 receptor-independent beneficial effects of telmisartan on dietary-induced obesity, insulin resistance and fatty liver in mice

(2010) X. Rong et al.   DIABETOLOGIA

Telmisartan Prevents Weight Gain and Obesity Through Activation of Peroxisome Proliferator-Activated Receptor-δ–Dependent Pathways

(2010) Hongbo He et al.   HYPERTENSION

Valsartan Protects Pancreatic Islets and Adipose Tissue From the Inflammatory and Metabolic Consequences of a High-Fat Diet in Mice

(2010) Banumathi K. Cole et al.   HYPERTENSION

Leptin at 14 y of age: an ongoing story

(2009) Jeffrey M Friedman   AMERICAN JOURNAL OF CLINICAL NUTRITION

Inhibiting angiotensin type 1 receptors as a target for diabetes

(2008) Ulrich Kintscher et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptors

(2008) Florian Gembardt et al.   FASEB JOURNAL